ホーム › 乳がん › カリフォルニア州 › Sacramento
Sacramento、CAにおける乳がんの臨床試験
Sacramentoとその周辺地域（約30マイル以内）の拠点で、乳がんに関する20件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
被験者募集中第3相
- University of California, Davis Comprehensive Cancer Center, Sacramento
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
被験者募集中第3相
- Sutter Inst Medical Research, Sacramento
- School Of Medicine, Sacramento
Distance-Based Exercise to Preserve Function and Prevent Disability
被験者募集中
- Kaiser Permanente-South Sacramento, Sacramento
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Mercy Cancer Center - Sacramento, Sacramento
- Woodland Memorial Hospital, Woodland · 16マイル先
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
被験者募集中第3相
- Research Site, Sacramento
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
被験者募集中健康なボランティア歓迎
- University of California Davis, Sacramento
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
被験者募集中第3相
- University Of California Davis Health System, Sacramento
ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health
被験者募集中観察研究
- UC Davis, Sacramento
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
被験者募集中第3相
- Dignity Health dba Health Research Institute, Sacramento
- Sutter Institute for Medical Research, Sacramento
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
被験者募集中第3相
- Kaiser Permanente Downtown Commons, Sacramento
- Mercy Cancer Center - Sacramento, Sacramento
- Sutter Medical Center Sacramento, Sacramento
- 他5件
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
被験者募集中健康なボランティア歓迎
- University of California, Davis, Sacramento
E-Mindfulness Approaches for Living After Breast Cancer
被験者募集中第3相
- Kaiser Permanente Downtown Commons, Sacramento
- Kaiser Permanente-South Sacramento, Sacramento
Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)
被験者募集中
- University of California, Davis, Sacramento
UHFUS Characterization of Normal Lymphatic Anatomy
被験者募集中
- University of California Davis Health, Sacramento
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
被験者募集中第2相
- University of California - Davis, Comprehensive Cancer Center, Davis · 14マイル先
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
被験者募集中第3相
- Kaiser Permanente Downtown Commons, Sacramento
- Mercy Cancer Center - Sacramento, Sacramento
- Sutter Medical Center Sacramento, Sacramento
- 他4件
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
被験者募集中第1/2相
- University of California, Davis Comprehensive Cancer Center, Sacramento
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
被験者募集中観察研究
- Kaiser Permanente Downtown Commons, Sacramento
- Mercy Cancer Center - Sacramento, Sacramento
- Kaiser Permanente-South Sacramento, Sacramento
- 他1件
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
被験者募集中第2相
- University of California Davis Comprehensive Cancer Center, Sacramento
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
被験者募集中第1相
- University of California Davis Comprehensive Cancer Center, Sacramento
他の都市における乳がんの試験
- New York City, NY136件の研究
- Houston, TX126件の研究
- Boston, MA112件の研究
- Nashville, TN81件の研究
- Los Angeles, CA73件の研究
- Edison, NJ68件の研究
- St. Louis, MO64件の研究
- Queens, NY64件の研究
- Durham, NC64件の研究
- Chicago, IL59件の研究
- Philadelphia, PA56件の研究
- Dallas, TX55件の研究
Sacramentoにおける他の研究
- 非小細胞肺癌29件の研究
- 肺がん22件の研究
- 前立腺がん19件の研究
- 転移性癌16件の研究
- 急性骨髄性白血病12件の研究
- 心不全12件の研究
- 膵臓がん12件の研究
- がん（全種類）11件の研究
- 結腸癌11件の研究
- 膀胱癌10件の研究
- 大腸癌10件の研究
- 2型糖尿病9件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。